157 related articles for article (PubMed ID: 34173348)
1. Impact of bromodomain-containing protein 4 (BRD4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity.
Chuang KT; Wang SN; Hsu SH; Wang LT
Cancer Med; 2021 Aug; 10(16):5545-5556. PubMed ID: 34173348
[TBL] [Abstract][Full Text] [Related]
2. PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition.
Wang LT; Liu KY; Jeng WY; Chiang CM; Chai CY; Chiou SS; Huang MS; Yokoyama KK; Wang SN; Huang SK; Hsu SH
EMBO Rep; 2020 Feb; 21(2):e48795. PubMed ID: 31908141
[TBL] [Abstract][Full Text] [Related]
3. PCAF, ISX, and BRD4: a maleficent alliance serving lung cancer malignancy.
Stemmler MP
EMBO Rep; 2020 Feb; 21(2):e49766. PubMed ID: 31908099
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma.
Hsu SH; Wang LT; Lee KT; Chen YL; Liu KY; Suen JL; Chai CY; Wang SN
Cancer Res; 2013 Jan; 73(2):508-18. PubMed ID: 23221382
[TBL] [Abstract][Full Text] [Related]
5. Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC.
Wang SN; Wang LT; Sun DP; Chai CY; Hsi E; Kuo HT; Yokoyama KK; Hsu SH
Oncotarget; 2016 Jun; 7(24):36924-36939. PubMed ID: 27175585
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance.
Wang LT; Liu KY; Chiou SS; Huang SK; Hsu SH; Wang SN
Cancer Lett; 2021 Nov; 520():160-171. PubMed ID: 34265398
[TBL] [Abstract][Full Text] [Related]
7. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhang P; Dong Z; Cai J; Zhang C; Shen Z; Ke A; Gao D; Fan J; Shi G
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):36-44. PubMed ID: 25816404
[TBL] [Abstract][Full Text] [Related]
8. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor promotes hepatocellular carcinoma tumorigenesis by targeting intestine-specific homeobox expression.
Hsu SH; Wang LT; Chai CY; Wu CC; Hsi E; Chiou SS; Wang SN
Mol Carcinog; 2017 Oct; 56(10):2167-2177. PubMed ID: 28398627
[TBL] [Abstract][Full Text] [Related]
10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
11. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM
Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918
[TBL] [Abstract][Full Text] [Related]
13. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
14. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
15. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
[TBL] [Abstract][Full Text] [Related]
16. Intestine-Specific Homeobox Gene
Wang LT; Chiou SS; Chai CY; Hsi E; Yokoyama KK; Wang SN; Huang SK; Hsu SH
Cancer Res; 2017 Aug; 77(15):4065-4077. PubMed ID: 28625979
[TBL] [Abstract][Full Text] [Related]
17. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
18. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.
Li Q; Liu Z; Xu M; Xue Y; Yao B; Dou C; Jia Y; Wang Y; Tu K; Zheng X; Yao Y
Cancer Lett; 2016 May; 375(1):190-198. PubMed ID: 26945969
[TBL] [Abstract][Full Text] [Related]
19. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
[TBL] [Abstract][Full Text] [Related]
20. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
